Entries of Jachimczak, P. on the publication server

Riechers, A., Schmidt, J., Dettmer, Katja , Oefner, Peter J. , Jachimczak, P., Schneider, A. and Bosserhoff, Anja-Katrin (2013) Inducing anti-tumor cytokines and an immune response in melanoma by inhibition of MIA using the peptide AR71. Eur J Dermatol 23 (6), pp. 820-825. Fulltext not available.

Bogdahn, Ulrich, Hau, Peter, Stockhammer, G., Venkataramana, N. K., Mahapatra, A. K., Suri, A., Balasubramaniam, A., Nair, S., Oliushine, V., Parfenov, V., Poverennova, I., Zaaroor, M., Jachimczak, P., Ludwig, S., Schmaus, S., Heinrichs, H. and Schlingensiepen, K. H. (2011) Targeted therapy for high-grade glioma with the TGF-β2 inhibitor trabedersen: results of a randomized and controlled phase IIb study. Neuro-oncology 13 (1), pp. 132-142. Fulltext not available.

Bogdahn, U., Stockhammer, G., Mahapatra, A. K., Venkataramana, N. K., Oliushine, V. E., Parfenov, V. E., Poverennova, I. E., Jachimczak, P., Heinrichs, H. and Schlingensiepen, K. (2010) Pseudoprogression after treatment with the TGF-beta 2 inhibitor trabedersen in high-grade glioma patients. Journal of Clinical Oncology 28 (15_sup), p. 2054. Fulltext not available.

Bogdahn, U., Zaaroor, M., Parfenov, V., Kunst, M., Mahapatra, A.K., Sastry, K.V.R., Jachimczak, P., Stockhammer, G., Rappaport, Z.H. and Schlingensiepen, K.H. (2006) 329 POSTER A phase llb study in patients with recurrent malignant glioma with the TGF-beta2 inhibitor AP 12009. European Journal of Cancer Supplements 4 (12), p. 103. Fulltext not available.

Jachimczak, P., Hessdörfer, B., Fabel-Schulte, K., Wismeth, C., Brysch, W., Schlingensiepen, K. H., Bauer, A., Blesch, A. and Bogdahn, U. (1996) Transforming growth factor-beta-mediated autocrine growth regulation of gliomas as detected with phosphorothioate antisense oligonucleotides. International journal of cancer. Journal international du cancer 65 (3), pp. 332-337. Fulltext not available.

Jachimczak, P., Fabel-Schulte, K., Hessdörfer, B., Brysch, W., Schlingensiepen, K. H., Blesch, A. and Bogdahn, U. (1995) Transforming growth factor-beta-mediated regulation of human peripheral blood mononuclear cell proliferation as detected with phosphorothioate antisense oligodeoxynucleotides. Cellular immunology 165 (1), pp. 125-133. Fulltext not available.

Blesch, A., Bosserhoff, Anja-Katrin, Apfel, R., Behl, C., Hessdoerfer, B., Schmitt, A., Jachimczak, P., Lottspeich, F., Buettner, R. and Bogdahn, Ulrich (1994) Cloning of a novel malignant melanoma-derived growth-regulatory protein, MIA. Cancer Research 54 (21), pp. 5695-5701.

Bogdahn, U., Fröhlich, T., Becker, G., Krone, A., Schlief, R., Schürmann, J., Jachimczak, P., Hofmann, E., Roggendorf, W. and Roosen, K. (1994) Vascularization of primary central nervous system tumors: detection with contrast-enhanced transcranial color-coded real-time sonography. Radiology 192 (1), pp. 141-148. Fulltext not available.

Jachimczak, P., Bogdahn, U., Schneider, J., Behl, C., Meixensberger, J., Apfel, R., Dörries, R., Schlingensiepen, K. H. and Brysch, W. (1993) The effect of transforming growth factor-beta 2-specific phosphorothioate-anti-sense oligodeoxynucleotides in reversing cellular immunosuppression in malignant glioma. Journal of neurosurgery 78 (6), pp. 944-951. Fulltext not available.